Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? Equity (Details Narrative)

v3.25.1
Stockholders’ Equity (Details Narrative) - USD ($)
 12 Months Ended
Dec. 24, 2024
Dec. 24, 2024
Jun. 13, 2024
Jun. 12, 2024
Jun. 22, 2022
Jan. 23, 2022
Oct. 19, 2021
Jan. 29, 2021
Dec. 22, 2020
Sep. 25, 2020
Jun. 22, 2020
Dec. 31, 2024
Dec. 31, 2023
Dec. 29, 2024
Dec. 19, 2024
Sep. 29, 2020
Sep. 30, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares granted                       893,181 893,181        
Number of additional granted shares issued                       120          
Aggregate vested shares value                       $ 2,009,657          
Number of unvested shares                       15,181          
Unrecognized value of shares                       $ 34,157          
Stock repurchase expiration date           Mar. 31, 2023                      
Shares repurchased and cancelled                         519,828        
Purchase price of shares repurchased and cancelled                         $ 7,536,216        
Number of shares issued, value                       $ 1,869,111          
Common stock, shares authorized                       100,000,000 100,000,000        
Common stock, par value                       $ 0.001 $ 0.001        
Issuance of common stock through partial exercise of underwriter warrants and gross proceeds             $ 562,596                    
Aggregate intrinsic value of outstanding warrants                       $ 81,553          
Closing share price                           $ 11.23      
Proceeds from sale of shares                       $ 2,499,998        
IPO [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Gross proceeds from sale of shares                   $ 7,250,002              
Underwriting discounts and commissions and offering expenses                   $ 1,042,500              
Number of shares issued                   1,260,870              
Public offering price                   $ 5.75              
Number of shares issued, value                   $ 6,207,502              
Exercised option to purchase of shares                   189,130              
Additional common shares issuable upon conversion of preferred stock                               42,404  
Conversion price per share                               $ 5.75  
Common stock, shares authorized                               100,000,000  
Common stock, par value                               $ 0.001  
Preferred stock, shares authorized                               10,000,000  
Preferred stock, par value                               $ 0.001  
IPO [Member] | Series A Preferred Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Converted shares of preferred stock into common stock                               1,520,937  
IPO [Member] | Series B Preferred Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Converted shares of preferred stock into common stock                               129,267  
IPO [Member] | Series C Preferred Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Converted shares of preferred stock into common stock                               66,575  
IPO [Member] | Series D Preferred Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Converted shares of preferred stock into common stock                               305,990  
Additional common shares issuable upon conversion of preferred stock                               42,404  
Follow On Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Gross proceeds from sale of shares                 $ 26,400,000                
Number of shares issued                 660,000                
Public offering price                 $ 40.00                
Exercised option to purchase of shares                 99,000                
Net proceeds from sale of shares                 $ 23,959,000                
Net of underwriting discount commission and offering expenses                 $ 2,441,000                
Over-Allotment Option [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Gross proceeds from sale of shares               $ 2,800,000                  
Underwriting discounts and commissions and offering expenses               $ 252,000                  
Public offering price               $ 40.00                  
Exercised option to purchase of shares               70,000                  
Net proceeds from sale of shares               $ 2,548,000                  
Private Placement [Member] | Chief Executive Officer and Director [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares sold     174,825                            
Shares sold price per share     $ 14.30                            
Proceeds from sale of shares       $ 2,499,998                          
ATM Agreement [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares sold                       129,739          
Shares sold price per share                       $ 15.92          
Gross proceeds from sale of shares                       $ 2,065,366          
Gross proceeds from sale of shares                       1,869,111          
Underwriting discounts and commissions and offering expenses                       $ 196,257          
Amended and Restated Certificate of Incorporation [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Reverse stock split                     1-for-2.67 reverse stock split            
Maximum [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock repurchase value           $ 10,000,000                      
Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares granted                       908,362 908,362        
Common stock grant vested shares                       0 0        
Number of shares issued                       129,739          
Number of shares issued, value                       $ 130          
Issuance of common stock through partial exercise of underwriter warrants, shares             80,696                    
Warrant [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrants expiration date [1]                       Sep. 24, 2025          
Warrant exercise price [1]                       $ 7.1875          
Warrant [Member] | IPO [Member] | Aegis Capital Corp [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Public offering price                   $ 6.9718              
Warrants to purchase of common stock                   100,870              
Sale of shares percentage                   8.00%              
Warrants expiration date                   Sep. 24, 2025              
Warrant exercise price                   $ 7.1875              
Public offering price, percentage                   125.00%              
Warrants exercise price, percentage                   97.00%              
2019 Equity Incentive Plan [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock capital shares reserved for future issuance                                 1,500,000
2024 Amended Equity Incentive Plan [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Common stock capital shares reserved for future issuance                             4,000,000    
Additional common stock capital shares reserved for future issuance                             2,500,000    
2019 Equity Incentive Plan [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares granted         1,498,128                        
Exercise price         $ 7.63                        
Stock granted                       $ 9,512,356          
Risk-free interest rate                       3.20%          
Voltality rate                       106.00%          
Compensation expense                       $ 6,004,672          
Fair value                       $ 3,507,684          
Vesting term                       4 years          
Two Thousand Twenty Four Equity Incentive Plan [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Number of shares granted   1,627,937                              
Exercise price   $ 12.16                              
Stock granted                       $ 16,190,565          
Risk-free interest rate                       4.50%          
Voltality rate                       103.00%          
Compensation expense                       $ 4,875,239          
Fair value                       $ 11,315,326          
Vesting term                       3 years          
Number of options vested and expected to vest 100,000 100,000                              
Vesting rights percentage 25.00%                     75.00%          
[1] The warrants are exercisable at any time and from time to time, in whole or in part, during a period commencing March 24, 2021 and expiring September 24, 2025. The exercise price of the warrants is $7.1875 per share or $6.9718 per share if the warrants are exercised for cash within the first six months of the period in which they are exercisable.